Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergan Ord Regulatory News (0Y7T)

Share Price Information for Allergan Ord (0Y7T)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.7529
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 177.7529
Low: 176.53
Yest. Close: 177.7529
0Y7T Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Northern Trust Corp - Form 8.3 - AbbVie Inc

Thu, 19th Sep 2019 15:21

RNS Number : 0143N
Northern Trust Corporation
19 September 2019
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

 Northern Trust Corporation

Company dealt in

 AbbVie Inc

Class of relevant security to which the dealings being disclosed relate (Note 2)

 Common Stock USD 0.01

Date of dealing

 18  September  2019

 

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 21,171,733   1.43%

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 21,171,733   1.43%

 

             

 

* Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 7735 securities into the accounts and 5 securities out of the relevant accounts.

 

 

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

             

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit ($)

SELL

441

71.27

BUY

121

71.27

BUY

459

71.27

SELL

1153

71.27

SELL

1061

71.27

BUY

985

71.27

BUY

258

71.27

BUY

234

71.27

BUY

62

71.27

BUY

7

71.27

BUY

11

70.87

BUY

65

70.87

BUY

150

70.87

BUY

270

70.87

BUY

25

70.87

BUY

22

70.87

SELL

144

70.88

BUY

45

70.87

BUY

30

71.27

SELL

108

71.1949

BUY

265

70.87

BUY

89

70.87

BUY

46

70.87

BUY

55

70.87

BUY

24

71.27

BUY

37

70.87

BUY

360

70.87

BUY

88

70.87

BUY

10

70.87

BUY

279

70.87

SELL

37

70.88

BUY

43

70.87

SELL

22

71.27

SELL

2985

71.1184

BUY

177

70.87

BUY

470

71.1936

BUY

10

70.87

BUY

167

71.1936

BUY

110

71.27

BUY

96

70.97

SELL

9

70.88

SELL

145

70.88

SELL

939

71.01

SELL

41

70.88

BUY

27

70.87

SELL

97

71.1949

BUY

25

70.87

BUY

645

70.87

BUY

81

70.87

SELL

49

70.88

BUY

36

70.87

BUY

31

70.87

SELL

26

70.88

BUY

36

70.87

SELL

57

70.88

BUY

392

71.06

SELL

77

70.88

BUY

15

70.87

SELL

8

70.88

BUY

50

70.87

BUY

210

70.87

BUY

6

70.87

BUY

692

71.1936

BUY

63

70.87

SELL

5

70.88

BUY

33

70.87

BUY

5

70.87

BUY

15

71.27

BUY

8

70.87

BUY

417

70.87

BUY

5

70.87

BUY

1

70.87

BUY

22

70.87

BUY

100

71.29

BUY

400

71.7

BUY

100

71.7

BUY

200

71.7

BUY

200

71.7

BUY

100

71.7

BUY

500

71.7

SELL

150

71.303

BUY

48

70.94

SELL

10

71.31

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing

and any other person relating to the voting rights of any relevant securities under any option

referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            NO

 

Date of disclosure

 19September 2019

Contact name

Frances MclIrath

Telephone number

442079823386

If a connected EFM, name of offeree/offeror with which connected

 

 

If a connected EFM, state nature of connection (Note 10)

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEUKASRKWAKAAR

Login to your account

Don't have an account? Click here to register.